Concepedia

Pamela Whalen

PW

Statistics

Publications

8

Citations

797

H-Index

8

Active since

2003

Affiliations

Pfizer (United States)(Current)

Morpho (United States)

Pamela Whalen is an author at Pfizer (United States) specializing in medicine, oncology, and pharmacology.

Publications per year

2003–2021

8

Publications

8

Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271

W. Gregory Roberts, Ethan Ung, Pamela Whalen et al. · Cancer Research · 2008 · 381 citations · Full text

, , +17

Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451

W. Gregory Roberts, Pamela Whalen, Erik Söderström et al. · Cancer Research · 2005 · 135 citations · Full text

, , +17

Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.

Jean S. Beebe, Jitesh P. Jani, Elisabeth Knauth et al. · PubMed · 2003 · 128 citations

, , +16

Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images

Sripad Ram, Pamela Vizcarra, Pamela Whalen et al. · PLoS ONE · 2021 · 74 citations · Full text

, , +17

Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90

Pramod P. Mehta, Pamela Whalen, Sangita M. Baxi et al. · Clinical Cancer Research · 2011 · 34 citations

, , +16

1–5 of 8